These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18061977)

  • 1. Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004.
    Cadarette SM; Katz JN; Brookhart MA; Levin R; Stedman MR; Choudhry NK; Solomon DH
    J Rheumatol; 2008 Feb; 35(2):319-26. PubMed ID: 18061977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010.
    Klop C; Gibson-Smith D; Elders PJ; Welsing PM; Leufkens HG; Harvey NC; Bijlsma JW; van Staa TP; de Vries F
    Osteoporos Int; 2015 Jul; 26(7):1919-28. PubMed ID: 25963232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of anti-osteoporosis medication dispensing by patients with hip fracture: could we do better?
    Kristensen PK; Ehrenstein V; Shetty N; Pedersen AB
    Osteoporos Int; 2019 Sep; 30(9):1817-1825. PubMed ID: 31263921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-osteoporosis medication treatment pattern after osteoporotic fracture during 2010-2016 in Fujian, China.
    Wang X; Li C; He Y; Wang T; Zhang H; Ma Z; Ma H; Zhao H
    Arch Osteoporos; 2020 Aug; 15(1):134. PubMed ID: 32820451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage.
    Cadarette SM; Carney G; Baek D; Gunraj N; Paterson JM; Dormuth CR
    Osteoporos Int; 2012 Apr; 23(4):1475-80. PubMed ID: 21901476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistance and Compliance with Osteroporosis Therapies Among Women in a Commercially Insured Population in the United States.
    Cheng LI; Durden E; Limone B; Radbill L; Juneau PL; Spangler L; Mirza FM; Stolshek BS
    J Manag Care Spec Pharm; 2015 Sep; 21(9):824-33, 833a. PubMed ID: 26308229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.
    Shah A; Prieto-Alhambra D; Hawley S; Delmestri A; Lippett J; Cooper C; Judge A; Javaid MK;
    Osteoporos Int; 2017 Jan; 28(1):169-178. PubMed ID: 27812809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient and physician predictors of post-fracture osteoporosis management.
    Block AE; Solomon DH; Cadarette SM; Mogun H; Choudhry NK
    J Gen Intern Med; 2008 Sep; 23(9):1447-51. PubMed ID: 18584260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
    Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
    J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011.
    Solomon DH; Johnston SS; Boytsov NN; McMorrow D; Lane JM; Krohn KD
    J Bone Miner Res; 2014 Sep; 29(9):1929-37. PubMed ID: 24535775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey.
    Gonnelli S; Caffarelli C; Iolascon G; Bertoldo F; Letizia Mauro G; Patti A; Nuti R
    Aging Clin Exp Res; 2017 Oct; 29(5):1031-1037. PubMed ID: 27943127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis.
    Desai RJ; Mahesri M; Abdia Y; Barberio J; Tong A; Zhang D; Mavros P; Kim SC; Franklin JM
    JAMA Netw Open; 2018 Jul; 1(3):e180826. PubMed ID: 30646034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and treatment of osteoporosis after hip fracture: comparison of sex and race.
    Antonelli M; Einstadter D; Magrey M
    J Clin Densitom; 2014; 17(4):479-83. PubMed ID: 24657109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of prescribing and adherence patterns of anti-osteoporotic medications post-admission for fragility type fracture in an urban teaching hospital and a rural teaching hospital in Ireland between 2005 and 2008.
    McGowan B; Bennett K; Casey MC; Doherty J; Silke C; Whelan B
    Ir J Med Sci; 2013 Dec; 182(4):601-8. PubMed ID: 23483361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do patients receive recommended treatment of osteoporosis following hip fracture in primary care?
    Petrella RJ; Jones TJ
    BMC Fam Pract; 2006 May; 7():31. PubMed ID: 16684358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence.
    Roerholt C; Eiken P; Abrahamsen B
    Osteoporos Int; 2009 Feb; 20(2):299-307. PubMed ID: 18551241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture.
    Jennings LA; Auerbach AD; Maselli J; Pekow PS; Lindenauer PK; Lee SJ
    J Am Geriatr Soc; 2010 Apr; 58(4):650-7. PubMed ID: 20398147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates.
    Gu T; Eisenberg Lawrence DF; Stephenson JJ; Yu J
    Clin Interv Aging; 2016; 11():1-8. PubMed ID: 26929609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice.
    Naik-Panvelkar P; Norman S; Elgebaly Z; Elliott J; Pollack A; Thistlethwaite J; Weston C; Seibel MJ
    BMC Fam Pract; 2020 Feb; 21(1):32. PubMed ID: 32050909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hip fracture rates and time trends in use of anti-osteoporosis medications in Denmark for the period 2005 to 2015: Missed opportunities in fracture prevention.
    Abrahamsen B; Skjødt MK; Vestergaard P
    Bone; 2019 Mar; 120():476-481. PubMed ID: 30583122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.